Overview

Prolonging Remission in Depressed Elderly (PRIDE)

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

This study will determine whether medications alone or medications and electroconvulsive therapy (ECT) work best to prevent depressive relapse and to improve quality of life for older people with severe mood disorders.

Phase:

Phase 4

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Lithium Carbonate
Venlafaxine Hydrochloride